Source link : https://www.newshealth.biz/health-news/guselkumab-provides-long-term-relief-in-psoriatic-arthritis/
TOPLINE: Guselkumab administered every 8 weeks (Q8W) leads to durable improvement in disease activity along with improvements in both skin and joint symptoms over 2 years in patients with psoriatic arthritis (PsA) who were previously naive to biologic treatment. METHODOLOGY: Researchers conducted a post hoc analysis of the phase 3 DISCOVER-2 trial to evaluate the […]
Author : News Health
Publish date : 2024-10-22 11:13:03
Copyright for syndicated content belongs to the linked Source.